Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery

被引：526
|
作者：
Christopoulos, A [1 ]
机构：
[1] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia
来源：
NATURE REVIEWS DRUG DISCOVERY | 2002年 / 1卷 / 03期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1038/nrd746
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Cell-surface receptors are the targets for more than 60% of current drugs. Traditionally, optimizing the interaction of lead molecules with the binding site for the endogenous agonist (orthosteric site) has been viewed as the best means of achieving selectivity of action. However, recent developments have highlighted the fact that drugs can interact with binding sites on the receptor molecule that are distinct from the orthosteric site, known as allosteric sites. Allosteric modulators could offer several advantages over orthosteric ligands, including greater selectivity and saturability of their effect.
引用
收藏
页码：198 / 210
页数：13
相关论文
共 50 条
  • [1] Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
    Arthur Christopoulos
    Nature Reviews Drug Discovery, 2002, 1 : 198 - 210
  • [2] Unmasking allosteric-binding sites: novel targets for GPCR drug discovery
    Casado-Anguera, Veronica
    Casado, Vicent
    EXPERT OPINION ON DRUG DISCOVERY, 2022, 17 (08) : 897 - 923
  • [3] Discovery of hidden allosteric sites as novel targets for allosteric drug design
    Lu, Shaoyong
    Ji, Mingfei
    Ni, Duan
    Zhang, Jian
    DRUG DISCOVERY TODAY, 2018, 23 (02) : 359 - 365
  • [4] Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery
    Wang, Ying
    Yu, Zhengtian
    Xiao, Wen
    Lu, Shaoyong
    Zhang, Jian
    DRUG DISCOVERY TODAY, 2020, 26 (03) : 690 - 703
  • [5] Novel modes of targeting allosteric sites at muscarinic receptors: Implications for drug discovery
    Valant, Celine
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 205 - 205
  • [6] GPCR drug discovery through the exploitation of allosteric drug binding sites
    Rees, S
    Morrow, D
    Kenakin, T
    RECEPTORS & CHANNELS, 2002, 8 (5-6): : 261 - 268
  • [7] Adventures in drug discovery: Potent agents based on ligands for cell-surface receptors
    Maryanoff, Bruce E.
    ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (11) : 831 - 840
  • [8] Allosteric Binding Sites On Nuclear Receptors: Focus On Drug Efficacy and Selectivity
    Fischer, Andre
    Smiesko, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [9] Allosteric binding sites on muscarinic receptors
    Ellis, J
    DRUG DEVELOPMENT RESEARCH, 1997, 40 (02) : 193 - 204
  • [10] Targeting cryptic allosteric sites of G protein-coupled receptors as a novel strategy for biased drug discovery
    Qiao, Xin
    Li, Xiaolong
    Zhang, Mingyang
    Liu, Ning
    Wu, Yanmei
    Lu, Shaoyong
    Chen, Ting
    PHARMACOLOGICAL RESEARCH, 2025, 212
12345